Clinical Scorecard: Increased Tuberculosis Transmission Linked to Cross-Border Mobility and Extended Diagnostic Delays: Advocating for Comprehensive Genomic Analysis

At a Glance

Key Highlights

• Integrating genomic data from Almería and Madrid helped identify a 13-case cluster spanning both regions.

• One patient had symptoms for at least a year before diagnosis. The authors considered the prolonged delay a likely contributor to extensive transmission.

• Follow-up interviews uncovered movements and possible exposure settings that initial investigations had not established.

• Targeted sequencing of 164 Madrid isolates identified four additional candidate cases, subsequently confirmed by whole-genome sequencing.

• Madrid lacked population-wide genomic surveillance, so the full extent of the cluster remains uncertain.

Guideline-Based Recommendations

The supplied paper is a transmission investigation, not a clinical guideline. The points below distinguish its findings from the authors’ proposed surveillance approaches.

Diagnosis

• One patient was diagnosed after at least a year of symptoms and had advanced TB at presentation. The study did not evaluate a new diagnostic test or provide diagnostic guidance.

Management

• The authors propose integrating genomic data across relevant regions to identify related cases that separate surveillance programs may miss.

Monitoring & Follow-up

• The authors propose detailed, genomically informed interviews to investigate possible links among clustered cases. They also describe targeted sequencing of strain-marker variants to track a cluster where comprehensive sequencing is unavailable.

Risks

• Prolonged diagnostic delay may permit further transmission. Geographic gaps in sequencing and epidemiological data may leave related cases or exposure links unidentified.

Patient & Prescribing Data

The investigation identified 13 related TB cases diagnosed in Almería and Madrid. The paper describes their epidemiological and genomic relationships; it does not evaluate prescribing practices or compare treatments.

Clinical Best Practices

The authors propose linking genomic surveillance and epidemiological investigation across regional boundaries, using structured follow-up interviews to clarify possible exposures, and examining genetic differences within clusters to refine possible transmission chronologies. The study illustrates these approaches in one cluster; it does not establish a formal clinical practice guideline.

Related Resources & Content

The following publication details appear in the supplied paper or its reference list:

• Saleeb SM, Vallejo-Godoy S, Marcos-Abellán A, et al. “Tuberculosis enhanced transmission due to interterritorial mobility and prolonged diagnostic delay: a call for an integrated genomic analysis.” International Journal of Infectious Diseases. 2026;172:109061.

• Walker TM, Ip CLC, Harrell RH, et al. “Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.” The Lancet Infectious Diseases. 2013;13:137–146.

• Golub J, Bur S, Cronin WA, et al. “Delayed tuberculosis diagnosis and tuberculosis transmission.” International Journal of Tuberculosis and Lung Disease. 2006;10:24–30.

• Rodríguez-Grande C, Vallejo-Godoy S, Martínez-Lirola M, et al. “Long-term refined genomic analysis of tuberculosis clusters to distinguish between ongoing transmission, reactivations or diagnostic delays, Almería, Spain, 2003 to 2024.” Eurosurveillance. 2026;31:2500301.

• Gardy JL, Johnston JC, Sui SJH, et al. “Whole-genome sequencing and social-network analysis of a tuberculosis outbreak.” New England Journal of Medicine. 2011;364:730–739.

• Li M, Quan Z, Xu P, Takiff H, Gao Q. “Internal migrants as drivers of long-distance cross-regional transmission of tuberculosis in China.” Clinical Microbiology and Infection. 2025;31:71–77.